Nucleos(t)ide Analog Therapy of Chronic Hepatitis B and Extrahepatic Cancer Risk: Is Tenofovir Better Than Entecavir?: Editorial on "Extrahepatic Malignancies and Antiviral Drugs for Chronic Hepatitis B: A Nationwide Cohort Study"

Overview

Journal Clin Mol Hepatol

Specialty Gastroenterology

Date 2024 Jul 8

PMID 38973180

Authors

Yewan Park

Dong Hyun Sinn

Affiliations

Soon will be listed here.

References

Tang L, Covert E, Wilson E, Kottilil S . Chronic Hepatitis B Infection: A Review. JAMA. 2018; 319(17):1802-1813. DOI: 10.1001/jama.2018.3795. View

Hur M, Lee D, Lee J, Kim M, Park J, Shin H . Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study. Clin Mol Hepatol. 2024; 30(3):500-514. PMC: 11261230. DOI: 10.3350/cmh.2024.0055. View

Yang H . Revisiting the natural history of chronic hepatitis B infection. Clin Liver Dis (Hoboken). 2024; 23(1):e0195. PMC: 11168840. DOI: 10.1097/CLD.0000000000000195. View

Choi J, Kim H, Lee J, Cho S, Ko M, Lim Y . Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study. JAMA Oncol. 2018; 5(1):30-36. PMC: 6439769. DOI: 10.1001/jamaoncol.2018.4070. View

Lee S, Choi J, Kim S, Lim Y . Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma. Clin Mol Hepatol. 2021; 27(3):402-412. PMC: 8273642. DOI: 10.3350/cmh.2021.0179. View

Lok A, McMahon B, Brown Jr R, Wong J, Ahmed A, Farah W . Antiviral therapy for chronic hepatitis B viral infection in adults: A systematic review and meta-analysis. Hepatology. 2015; 63(1):284-306. DOI: 10.1002/hep.28280. View

Chon Y, Park S, Park M, Ha Y, Lee J, Lee K . Extrahepatic Malignancies Are the Leading Cause of Death in Patients with Chronic Hepatitis B without Cirrhosis: A Large Population-Based Cohort Study. Cancers (Basel). 2024; 16(4). PMC: 10886555. DOI: 10.3390/cancers16040711. View

Fwu C, Chien Y, You S, Nelson K, Kirk G, Kuo H . Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology. 2011; 53(4):1217-25. DOI: 10.1002/hep.24150. View

Hong C, Sinn D, Kang D, Paik S, Guallar E, Cho J . Incidence of extrahepatic cancers among individuals with chronic hepatitis B or C virus infection: A nationwide cohort study. J Viral Hepat. 2020; 27(9):896-903. DOI: 10.1111/jvh.13304. View

10.

. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018; 3(6):383-403. DOI: 10.1016/S2468-1253(18)30056-6. View

11.

Lee D, Chung S, Lee J, Kim H, Chung G, Kim M . Association of Chronic Hepatitis B Infection and Antiviral Treatment With the Development of the Extrahepatic Malignancies: A Nationwide Cohort Study. J Clin Oncol. 2022; 40(29):3394-3405. DOI: 10.1200/JCO.21.01285. View

12.

. KASL clinical practice guidelines for management of chronic hepatitis B. Clin Mol Hepatol. 2022; 28(2):276-331. PMC: 9013624. DOI: 10.3350/cmh.2022.0084. View

13.

Tan R, Zhu X, Sun Y, Yang S, Peng C, Feng X . The association of HBV infection and head and neck cancer: a systematic review and meta-analysis. BMC Cancer. 2024; 24(1):225. PMC: 10874002. DOI: 10.1186/s12885-024-11967-7. View